Skip to main content
. 2011 Mar;6(3):519–527. doi: 10.2215/CJN.06370710

Table 2.

Comparisons between ESRD and LVH patients

Variable ESRD (n = 200) LVH Only (n = 30)
MTWA abnormala 115 (57.5) 8 (26.7)
Age (years) 56.3 (12.7) 53.1 (10.7)
Male (%) 142 (71) 25 (83.3)
BMI (kg/m2) 26.5 (4.7) 27.1 (4.9)
Systolic BP (mmHg) 146 (24.1) 152 (22.5)
Diastolic BP (mmHg)a 82 (14.2) 89 (11.1)
Diabetes mellitus 54 (27.0) 0
IHD 49 (24.5) 2 (9.5)
Heart failure 15 (7.5) 1 (3.3)
Cerebrovascular disease 26 (13) 1 (3.3)
Peripheral vascular disease 35 (17.5) 0
Dyslipidemia 117 (58.5) 10 (33.3)
Smoking
    never 89 (44.5) 19 (61.9)
    current/former 111 (55.5) 11 (38.1)
Epo receptor agonist 162 (81.0) 0
β-Adrenoceptor blocker 92 (46.0) 10 (33.3)
Aspirin 102 (51.0) 3 (10)
Warfarin 13 (6.5) 0
Clopidogrel 17 (8.5) 0
ACEI/ARB 91 (45.5) 12 (40.0)
Diuretic 58 (29) 6 (20.0)
Nitrate 15 (7.5) 8 (26.7)
Calcium channel blocker 76 (38.0) 8 (26.7)
α-Adrenoceptor blocker 24 (12.0) 1 (3.3)
Statin 125 (62.5) 9 (30.0)
Hemoglobin (g/dl) 11.4 (1.8) 11.4 (1.8)
ESR (mm/h) 29 (9.5, 49.0) 31 (14.5, 44.0)
CRP (mg/L) 4.9 (2.0, 9.9) 5.0 (3.2, 16.0)
Potassium (mmol/L) 4.7 (0.7) 4.7 (0.8)
Adjusted calcium (mmol/L) 2.39 (0.3) 2.41 (0.1)
Phosphate (mmol/L)a 1.61 (0.5) 1.10 (0.1)
Glucose (mmol/L) 5.5 (4.7, 7.7) 5.1 (4.6, 6.1)
CMR results
    EF (%) 61.9 (15.3) 65.8 (11.5)
    myocardial mass/BSA (g/m2) 93.3 (38.2) 82.0 (32.9)
    EDV/BSA (ml/m2 ) 68.9 (35.6) 67.1 (13.7)
    ESV/BSA (ml/m2 ) 28.7 (26.2) 23.5 (12.4)
    LVH on MRI 124 (62.0) 18 (60.0)
    LVSD on MRI (EF < 55%) 45 (22.5) 4 (13.8)
    LV dilation 19 (9.5) 2 (6.9)

Data are number with percentage in parentheses or mean ± SD except for ESR, CRP, and glucose, where median and interquartile range are shown. Tests of significance are t test, χ2, or Fischer exact test as appropriate.

a

P < 0.05.